Management and outcomes of thoracic sarcomas - a collaboration between Orthopaedic Oncology and cardiothoracic surgery: seven-year clinical data from a tertiary referral centre
Our results indicate that primary resection remains the cornerstone of thoracic sarcoma treatment, representing the single strongest independent factor for survival in treatable cases. Variability in outcomes and overall survival likely stems from factors such as histological diversity, predominance of high-grade sarcomas, and wide age range at diagnosis. Ongoing prospective database update and collaborative efforts across centres would further clarify prognoses and recommendations for specific tumours, based on observational data.
Authors
- C. L. M. H. Gibbons (ORCID: https://orcid.org/0000-0002-1378-9173)
- Vlad Paraoan
- Sarah Raihanah Saifuddin
- Dionisios Stavroulias
- Chang Wook Kim (ORCID: https://orcid.org/0000-0003-1184-0358)
- Duncan Whitwell
- Francesco DiChiara
- Z. Shamsi
- Thomas D A Cosker
Institutions
- University Hospitals of North Midlands NHS Trust (GB)
- Nuffield Orthopaedic Centre (GB)
- John Radcliffe Hospital (GB)
- University of Oxford (GB)
- Coventry (United Kingdom) (GB)
- Science Oxford (GB)
Publication Details
- Journal
- Journal of Cardiothoracic Surgery
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1186/s13019-025-03341-w
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00